Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Diseases ; 6(1)2017 Dec 26.
Article in English | MEDLINE | ID: mdl-29278399

ABSTRACT

Myanmar is adjacent to India, Bangladesh, Thailand, Laos and China. In Myanmar, the prevalence of hepatitis B virus (HBV) infections is 6.5% and accounts for 60% of hepatocellular carcinoma. HBV has nine genotypes that have been identified by molecular genetic analysis. HBV genotypes are associated with several clinical features. We reviewed the prevalence of HBV genotypes in Myanmar and neighboring countries. We also reviewed HBV genotypes in refugees from Myanmar. HBV subgenotype C1 is predominant in Myanmar. As HBV genotype C is associated with hepatocellular carcinoma (HCC), it is important to screen for cirrhosis and HCC and to prevent their development in HBV-infected individuals of Myanmar.

2.
Biochem Biophys Res Commun ; 483(1): 694-699, 2017 01 29.
Article in English | MEDLINE | ID: mdl-27986562

ABSTRACT

Although the interaction between host and hepatitis A virus (HAV) factors could lead to severe hepatitis A, the exact mechanism of acute liver failure caused by HAV infection is not yet fully understood. The effects of metabolic diseases such as dyslipidemia or diabetes mellitus on HAV replication are still unknown. Here, we examined the effects of free fatty acids or high-concentration glucose on HAV replication and the effects on mitogen-activated protein kinase signaling pathway-related genes in human hepatocytes. We discovered a novel effect of free fatty acids or high-concentration glucose on HAV replication in association with a reduction in the expression of glucose-regulated protein 78 (GRP78). We also observed that thapsigargin induced GRP78 expression and inhibited HAV replication. These findings may provide a new interpretation of the relationship between metabolic diseases and severity of hepatitis A and suggest a new understanding of the mechanism of severe HAV infection.


Subject(s)
Fatty Acids, Nonesterified/pharmacology , Glucose/pharmacology , Heat-Shock Proteins/metabolism , Hepatitis A virus/drug effects , Hepatitis A/virology , Host-Pathogen Interactions , Virus Replication/drug effects , Cell Line, Tumor , Down-Regulation , Endoplasmic Reticulum Chaperone BiP , Heat-Shock Proteins/genetics , Hepatitis A/complications , Hepatitis A virus/physiology , Hepatocytes/drug effects , Hepatocytes/virology , Humans , MAP Kinase Signaling System/drug effects , Metabolic Diseases/complications , Thapsigargin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...